POS0603 CARDIOVASCULAR RISK FACTORS BEFORE ONSET OF RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH CARDIOVASCULAR EVENTS AFTER DISEASE ONSET – A CASE CONTROL STUDY

Background Increased comorbidity and mortality in rheumatoid arthritis (RA) patients are highly due to cardiovascular disease (CVD). The etiology of this increased morbidity and mortality in patients with RA compared with the general population is not fully understood. We have previously shown that...

Full description

Bibliographic Details
Published in:Annals of the Rheumatic Diseases
Main Authors: Kokkonen, H., Johansson, L., Stenlund, H., Rantapää Dahlqvist, S.
Format: Article in Journal/Newspaper
Language:English
Published: BMJ 2022
Subjects:
Online Access:http://dx.doi.org/10.1136/annrheumdis-2022-eular.2561
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2022-eular.2561
id crjcrbmj:10.1136/annrheumdis-2022-eular.2561
record_format openpolar
spelling crjcrbmj:10.1136/annrheumdis-2022-eular.2561 2024-02-11T10:07:10+01:00 POS0603 CARDIOVASCULAR RISK FACTORS BEFORE ONSET OF RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH CARDIOVASCULAR EVENTS AFTER DISEASE ONSET – A CASE CONTROL STUDY Kokkonen, H. Johansson, L. Stenlund, H. Rantapää Dahlqvist, S. 2022 http://dx.doi.org/10.1136/annrheumdis-2022-eular.2561 https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2022-eular.2561 en eng BMJ Annals of the Rheumatic Diseases volume 81, issue Suppl 1, page 569.1-569 ISSN 0003-4967 1468-2060 General Biochemistry, Genetics and Molecular Biology Immunology Immunology and Allergy Rheumatology journal-article 2022 crjcrbmj https://doi.org/10.1136/annrheumdis-2022-eular.2561 2024-01-26T10:14:09Z Background Increased comorbidity and mortality in rheumatoid arthritis (RA) patients are highly due to cardiovascular disease (CVD). The etiology of this increased morbidity and mortality in patients with RA compared with the general population is not fully understood. We have previously shown that individuals who subsequently develop RA have increased frequencies of several risk factors for CVD, such as elevated BMI, elevated Apoliprotein (Apo) B/ApoA1 ratio, and cigarette smoking compared with matched controls, already before symptom onset of RA. Objectives We aimed to assess the impact of CV risk factors, already present before onset of symptoms of RA, for future CV events (CVE) in comparison with matched controls. Methods A case-control study including 521 individuals before symptoms of RA and 1,566 matched controls identified in the Health Surveys of the Medical Biobank of Northern Sweden was performed. Information regarding the presence of the selected risk factors for CVD was based on surveys with data collected in the Västerbotten Intervention Programme (VIP) and the Northern Sweden Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA). Selected CVD risk factors were: hypertension, elevated Apolipoprotein B/A1 ratio, elevated body mass index, diabetes, and smoking. Information on comorbidities (coded according to the International Statistical Classification of Diseases and Related Health Problems ninth or tenth revision (ICD-9 and/or -10)) was requested from the Swedish National Patient Register and the Cause of Death Register. Statistics were performed using SPSS version 26.0 (IBM Corp., NY, USA), Cox proportional hazard regression was used and presented with calculated hazard ratios (HRs) and 95% confidence intervals (CI). Adjustments were performed for risk factors developed after RA onset. Results Pre-RA individuals had a higher risk for CVE after RA onset compared with matched controls (HR (95% CI)= 1.70 (1.31-2.21)) which remained after adjustment for various risk ... Article in Journal/Newspaper Northern Sweden The BMJ Annals of the Rheumatic Diseases 81 Suppl 1 569.1 569
institution Open Polar
collection The BMJ
op_collection_id crjcrbmj
language English
topic General Biochemistry, Genetics and Molecular Biology
Immunology
Immunology and Allergy
Rheumatology
spellingShingle General Biochemistry, Genetics and Molecular Biology
Immunology
Immunology and Allergy
Rheumatology
Kokkonen, H.
Johansson, L.
Stenlund, H.
Rantapää Dahlqvist, S.
POS0603 CARDIOVASCULAR RISK FACTORS BEFORE ONSET OF RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH CARDIOVASCULAR EVENTS AFTER DISEASE ONSET – A CASE CONTROL STUDY
topic_facet General Biochemistry, Genetics and Molecular Biology
Immunology
Immunology and Allergy
Rheumatology
description Background Increased comorbidity and mortality in rheumatoid arthritis (RA) patients are highly due to cardiovascular disease (CVD). The etiology of this increased morbidity and mortality in patients with RA compared with the general population is not fully understood. We have previously shown that individuals who subsequently develop RA have increased frequencies of several risk factors for CVD, such as elevated BMI, elevated Apoliprotein (Apo) B/ApoA1 ratio, and cigarette smoking compared with matched controls, already before symptom onset of RA. Objectives We aimed to assess the impact of CV risk factors, already present before onset of symptoms of RA, for future CV events (CVE) in comparison with matched controls. Methods A case-control study including 521 individuals before symptoms of RA and 1,566 matched controls identified in the Health Surveys of the Medical Biobank of Northern Sweden was performed. Information regarding the presence of the selected risk factors for CVD was based on surveys with data collected in the Västerbotten Intervention Programme (VIP) and the Northern Sweden Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA). Selected CVD risk factors were: hypertension, elevated Apolipoprotein B/A1 ratio, elevated body mass index, diabetes, and smoking. Information on comorbidities (coded according to the International Statistical Classification of Diseases and Related Health Problems ninth or tenth revision (ICD-9 and/or -10)) was requested from the Swedish National Patient Register and the Cause of Death Register. Statistics were performed using SPSS version 26.0 (IBM Corp., NY, USA), Cox proportional hazard regression was used and presented with calculated hazard ratios (HRs) and 95% confidence intervals (CI). Adjustments were performed for risk factors developed after RA onset. Results Pre-RA individuals had a higher risk for CVE after RA onset compared with matched controls (HR (95% CI)= 1.70 (1.31-2.21)) which remained after adjustment for various risk ...
format Article in Journal/Newspaper
author Kokkonen, H.
Johansson, L.
Stenlund, H.
Rantapää Dahlqvist, S.
author_facet Kokkonen, H.
Johansson, L.
Stenlund, H.
Rantapää Dahlqvist, S.
author_sort Kokkonen, H.
title POS0603 CARDIOVASCULAR RISK FACTORS BEFORE ONSET OF RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH CARDIOVASCULAR EVENTS AFTER DISEASE ONSET – A CASE CONTROL STUDY
title_short POS0603 CARDIOVASCULAR RISK FACTORS BEFORE ONSET OF RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH CARDIOVASCULAR EVENTS AFTER DISEASE ONSET – A CASE CONTROL STUDY
title_full POS0603 CARDIOVASCULAR RISK FACTORS BEFORE ONSET OF RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH CARDIOVASCULAR EVENTS AFTER DISEASE ONSET – A CASE CONTROL STUDY
title_fullStr POS0603 CARDIOVASCULAR RISK FACTORS BEFORE ONSET OF RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH CARDIOVASCULAR EVENTS AFTER DISEASE ONSET – A CASE CONTROL STUDY
title_full_unstemmed POS0603 CARDIOVASCULAR RISK FACTORS BEFORE ONSET OF RHEUMATOID ARTHRITIS ARE ASSOCIATED WITH CARDIOVASCULAR EVENTS AFTER DISEASE ONSET – A CASE CONTROL STUDY
title_sort pos0603 cardiovascular risk factors before onset of rheumatoid arthritis are associated with cardiovascular events after disease onset – a case control study
publisher BMJ
publishDate 2022
url http://dx.doi.org/10.1136/annrheumdis-2022-eular.2561
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2022-eular.2561
genre Northern Sweden
genre_facet Northern Sweden
op_source Annals of the Rheumatic Diseases
volume 81, issue Suppl 1, page 569.1-569
ISSN 0003-4967 1468-2060
op_doi https://doi.org/10.1136/annrheumdis-2022-eular.2561
container_title Annals of the Rheumatic Diseases
container_volume 81
container_issue Suppl 1
container_start_page 569.1
op_container_end_page 569
_version_ 1790605324429819904